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A 31-year-old male patient was admitted to a tertia-
ry hospital due to chest pain, dyspnea, fever, and cough 
lasting a  week before admission. The patient reported 
a  respiratory tract infection a  month earlier. On admis-
sion an elevated level of leukocytes up to 6.80 × 109/l and 
C-reactive protein up to 105.2 mg/l were found. On chest 
X-ray enlargement of the heart was observed with no ab-
normalities in ECG (Figure 1 A). As in the echocardiography 
a significant amount of fluid was found in the pericardium 
an initial diagnosis of pericarditis was established. The 
patient was successfully treated pharmacologically and 
after nine days was discharged home in good condition. 
He was scheduled for rheumatology consultation. After 
2 weeks, in control echocardiography no abnormalities were 
found. However, after 3.5 months, he was admitted again 
due to severe dyspnea and atypical chest pain. On X-ray, 
the presence of many circular lesions in both lungs was 
confirmed. Also, in the echocardiogram a  large tumor in 
the right heart ventricle was observed (Figure 1 B). Chest 
computed tomography (CT) confirmed the presence of the 
tumor of the right heart and metastatic lesions in both 
lungs (Figure 1 C). The patient was transferred to the refer-
ence center for further assessment and treatment. Control 
echocardiography, CT, cardiac magnetic resonance (CMR) 
as well as positron emission tomography (PET) scans were 
performed to confirm expansion of the tumor within the 
heart walls (Figures 1 D, E). Coronarography was done to 
visualize potential connections between coronary arteries 
and tumor vessels (Figure 1 F). The myocardial biopsy con-
firmed the presence of angiosarcoma of the heart. The pa-
tient was discussed by the Heart Team and, at that stage, 
was disqualified from surgery. He was scheduled for pal-
liative chemotherapy with doxorubicin (75 mg/m²). Echo-
cardiographic follow-up was performed every 3 weeks 
before each cycle of chemotherapy, but only a  small 
reduction in the size of the tumor was observed (Fig- 
ure 1 G). Due to the limited response to chemotherapy, 
the patient was disqualified from surgery again. In the 
control CT scan, progression of tumor growth with nu-
merous metastatic lesions in the lungs was observed (Fig- 
ure 1 H). Gradual worsening of symptoms was observed, 
and the patient died 7 months after the diagnosis.
Primary heart tumors are relatively rare and only 25% 
of heart tumors are malignant (mostly represented by 
angiosarcoma) [1]. Heart angiosarcoma more often af-
fects young patients, especially men [1]. Most frequently, 
angiosarcoma of the heart occurs in the right atrium with 
a tendency to infiltrate surrounding tissues (pericardium, 
large vessels). The localization of angiosarcoma within 
the right ventricle is exceptional (about 4% of cases). 
Due to its primary localization, clinical symptoms at the 
beginning are not characteristic. For instance, the first 
manifestation of the heart angiosarcoma could be peri-
cardial effusion, as in our case [2]. However, in the case of 
pericardial effusion, further diagnostics more frequently 
lead to the confirmation of myocarditis, rheumatologic 
diseases, or collagenases, especially in young patients. 
More noticeable symptoms such as easy fatigue, dys-
pnea, and right-sided cardiac failure are usually associat-
ed with the dynamic growth of the tumor mass [1]. Apart 
from echocardiography, CT, CMR, and PET are routinely 
performed for precise visualization, tumor infiltration of 
local structures, and possible metastatic lesions [3, 4]. 
Imaging studies are crucial in cases scheduled for cardi-
ac surgery. Possible therapeutic options include cardiac 
surgery, radiotherapy, or aggressive chemotherapy. How-
ever, in most cases, the prognosis is poor, with a median 
survival of less than 11 months after the diagnosis [5].
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Figure 1. Heart angiosarcoma in the 31-year-old man. A – initial electrocardiogram without any significant 
abnormalities, B – echocardiogram with a large tumor in the right heart ventricle, C – chest computed tomog-
raphy (CT) with the presence of the tumor of the right heart and metastatic lesions in both lungs, D, E – CT and 
positron emission tomography (PET) scans, F – coronary angiogram showing connections between coronary 
arteries and tumor vessels, G, H – follow-up echocardiography and CT scan
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